I think it was actually myself reporting the Erin Saga after the Sydney Investor presentation. CN's initial comment was not off the cuff. She spoke about the Gambia and Erin's holding, as well as Erin having just entered preliminary bankruptcy. She spoke about the $ 5 mill Erin was owing to the Government and that there may be a possibility for FAR to acquire Erin's stake. It was FAR down in the future since the Erin's saga needed to be resolved. She took a few questions after the presentation and before tea and biscuits. First question was, if FAR pays Erin's $ 5 mill do we get their 20% share. Answer was, it may be possible but it is the Governments call and a fair bit in the future. She uttered similar words since, which could have been interpreted as "it's ours". And now she delivered. To have 10% in lieu of 20% is ok. Maybe if the 10% would have gone to another player it would be different. But to be acquired by Petronas is rather good news.
- Forums
- ASX - By Stock
- FAR
- *FAR Price Target Cut 40% to A$0.06/Share by Morgan Stanley
*FAR Price Target Cut 40% to A$0.06/Share by Morgan Stanley, page-111
-
- There are more pages in this discussion • 166 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add FAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
49.5¢ |
Change
-0.010(1.98%) |
Mkt cap ! $45.74M |
Open | High | Low | Value | Volume |
50.5¢ | 50.5¢ | 49.5¢ | $26.98K | 54.03K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 20223 | 49.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
50.5¢ | 611 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 20223 | 0.495 |
1 | 2000 | 0.485 |
2 | 28930 | 0.480 |
2 | 70000 | 0.475 |
2 | 78150 | 0.470 |
Price($) | Vol. | No. |
---|---|---|
0.505 | 611 | 1 |
0.510 | 59999 | 2 |
0.525 | 69690 | 1 |
0.530 | 30000 | 1 |
0.535 | 30000 | 1 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
FAR (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online